期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 49, 期 2, 页码 740-747出版社
AMER CHEMICAL SOC
DOI: 10.1021/jm050699p
关键词
-
资金
- NCI NIH HHS [CA85240] Funding Source: Medline
- NHLBI NIH HHS [HL078641] Funding Source: Medline
- NIBIB NIH HHS [EB004626] Funding Source: Medline
- NIGMS NIH HHS [R01 GM041890] Funding Source: Medline
We report on C20-6-(N-methylamino)hexanoic conjugates of wortmannin featuring a tertiary enamine attached to the C20 that inhibit phosphoinositol-3-OH kinase (PI3K) by producing wortmannin (Win) through an intramolecular attack. The generation of Win by these conjugates permits the design of Wm based PI3K inhibitors that need not fit into the ATP pocket of PI3K, including Win conjugates of BSA, IgG, or beads. Win generating WmC20-N(Me)-hexanoate conjugates offer an approach to the design of targeted or slow release forms of Win which may inhibit PI3K in tissues more selectively than the parent Win, a compound which has desirable anti-inflammatory and anti-proliferative activities but which also has a variety of toxic effects.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据